Evidence map›Paper›PMID 41659892›Full record

ArticleBioMed research international2026

An Investigation of Colistin Heteroresistance in

Zohreh Riahi Rad, Zahra Riahi Rad, Hossein Goudarzi, Mehdi Goudarzi, Mohsen Javidi, Javad Yasbolaghi Sharahi, Masoud Kargar, Ali Hashemi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. An Investigation of Colistin Heteroresistance inBioMed research international · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zohreh Riahi RadDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0000-0002-0032-5329
Zahra Riahi RadDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0000-0002-2904-618X
Hossein GoudarziDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0000-0002-3052-6447
Mehdi GoudarziDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0000-0001-6720-9341
Mohsen JavidiDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0009-0009-9301-616X
Javad Yasbolaghi SharahiDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0000-0002-5183-6153
Masoud KargarThalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran, ajums.ac.ir.ORCID https://orcid.org/0000-0003-2771-8939
Ali HashemiDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0000-0002-7258-5541

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: According to the World Health Organization 2024 bacterial priority pathogens list, carbapenem-resistant Methods: Between 2019 and 2020, 100 Results: The MIC test showed that 79 (79%) of the 100 Conclusions: In conclusion, the current study contributes to our understanding of the challenges posed by heteroresistant isolates in clinical laboratories. Since heteroresistant isolates may be misidentified as susceptible by standard tests, these findings raise concerns regarding the interpretation of colistin susceptibility results.

Indexed as

Anti-Bacterial AgentsColistinDrug Resistance, BacterialKlebsiella InfectionsKlebsiella pneumoniaeHumansIranMicrobial Sensitivity TestsMultilocus Sequence TypingAnti-Bacterial AgentsColistinantibiotic resistancecarbapenem-resistant K. pneumoniae (CRKP)colistinheteroresistanceKlebsiella pneumoniaepopulation analysis profiles

Identifiers

PMID41659892
PMCPMC12872957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.